Latest Capital Raising News

TruScreen Limited has obtained a waiver from NZ RegCo allowing it to allot oversubscribed shares up to 10 business days after its capital raising offer closes, subject to shareholder approval. This move aims to streamline the company’s NZ$3 million placement and share purchase plan.

Prospech Limited has successfully raised $1 million through a 50 million share placement, aiming to accelerate exploration efforts in Finland and Slovakia, with a particular focus on expanding the Korsnäs resource.

TruScreen Group Limited has announced a capital raising initiative involving Placement and Share Purchase Plan (SPP) Options, aiming to secure approximately NZ$3 million to fund strategic growth and working capital needs. The offer, subject to shareholder approval, includes up to 80.9 million Placement Options and 55.5 million SPP Options exercisable at A$0.02.

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

TruScreen Group Limited has launched a NZ$1.22 million Share Purchase Plan offering discounted shares to eligible investors, aiming to fuel growth in key international markets and public health initiatives.

TruScreen Group Limited forecasts a robust 64% increase in FY26 sales, driven by strategic market expansions and new distribution agreements. The company’s AI-enabled cervical cancer screening technology is gaining traction across emerging markets.

TruScreen Group Limited has announced a NZ$3 million capital raise to fund strategic growth initiatives across Asia and Africa, alongside repaying existing debt. The raise includes a placement and share purchase plan with free attaching options, signaling confidence in its expanding cervical cancer screening programs.

QEM Limited's trading suspension has been lifted immediately following its announcement of a new capital raise, signaling a pivotal moment for the company’s financial strategy.

QEM Limited has raised A$2.05 million through a strongly supported placement to accelerate its Julia Creek Vanadium and Energy Project, coinciding with the retirement of founding CEO Gavin Loyden and the appointment of Robert Cooper as his successor.

Gold Mountain Limited has issued nearly 486 million shortfall shares to underwriter Jose Luis Manzano, lifting its recent trading halt. A second tranche to Magnus Capital awaits shareholder approval, marking a pivotal step in the company’s capital raising.

Ionic Rare Earths has announced a $3 million capital raise via convertible notes, aimed at advancing its rare earth projects across multiple continents. The raise, pending shareholder approval, underscores the company’s strategic push into sustainable rare earth extraction and recycling technologies.

Uvre has cleared a crucial regulatory hurdle in its acquisition of New Zealand’s Waitekauri Gold Project, setting the stage for new leadership and exploration activities.